Drugs are mostly viscous and has various formulations (intravenous,
intramuscular, and subcutaneous) that needs to be absorbed into
digestive tract, which raise multiple drug delivery issue with
traditional drug delivery system. Moreover, such issues not only
raise costs but also decrease satisfaction and compliance of
patients. Wearable
injectors or bolus injectors are the new class for drug
delivery device designed for subcutaneous delivery. It has capacity
to hold the drug volume of up to 2.5 ml. Wearable injectors are easy
to handle, low cost, disposable, and allow self-administration.
Advancement in injector technology over traditional drug delivery
system include single button to release the drug and after completion
of drug in body, the needle is retracted and gets locked
automatically. Thus, it’s safe and convenient disposable system
benefits people who has needle phobia. Furthermore, it allows audible
and visual signals, which is expected to fuel the growth of wearable
injector market during forecast period.
Download
PDF Brochure of This Business Report @
https://www.coherentmarketinsights.com/insight/request-pdf/970
Strategies to improve drug delivery system through the
introduction of new wearable injectors is expected to propel the
growth of wearable injector market
In 2015, Unilife Corporation introduced Imperium, which is an instant
patch pump used for insulin. Imperium is a subcutaneous insulin
infusion, disposable, prefilled, and multi-day wearable insulin pump.
It has various features that include data connectivity for app to
constantly remind and update wireless connectivity such as Bluetooth
LE. It also provide real-time access to healthcare provider to track
the insulin therapy of each patient.
In 2014, Enable Injections LLC has signed an agreement with CSL
Behring to develop novel drug delivery devices. Enable Injectors
intent to improve comfort, convenience, and compliance administrative
device for the patients with rare diseases.
Enable Injection LLC and Flex entered in agreement to develop and
manufacture wearable medical device in 2016. Enable and Flex aims to
develop subcutaneous pain-free injection technology with features
such as Bluetooth connectivity, monitoring system with smartphone
app, mix automation, and passive warming system.
Some of the key players operating in the global wearable injector
market include;
Medtronic Plc, West Pharmaceutical Services, Inc., Enable Injections,
F. Hoffmann-La Roche Ltd, scPharmaceuticals, Inc, Johnson &
Johnson, Insulet Corporation, Sensile Medical Ag, Becton, and
Dickinson And Company.
Grab Your Report at an Impressive Discount @
https://www.coherentmarketinsights.com/insight/request-discount/970
Wearable Injector Market Taxonomy:
By Product type:
• On-body (Adhesive patch)
• Off-body (Belt clip)
• Hand-Held
By Usage:
• Disposable
• Semi-Reusable
By Technology:
• Spring-based
• Motor-driven
• Rotary Pump
• Expanding battery
• Pressurized Gas
• Collapsible Reservoir
By Application:
• Cardiovascular
• Autoimmune diseases
• Diabetes
• Oncology
• Infectious Diseases
• Others
By End-use Industry:
• Hospital
• Clinics
• Home-care
• Ambulatory Service
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment